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Abstract 1 
This study examined the effects of acute supplementation with L-arginine and nitrate on 2 
running economy, endurance and sprint performance in endurance-trained athletes. In a 3 
randomized cross-over, double-blinded design we compared the effects of combined 4 
supplementation with 6 g L-arginine and 614 mg nitrate against 614 mg nitrate alone and 5 
placebo in nine male elite cross-country skiers (age 18±0 years, VO2max 69.3±5.8 ml·min
-6 
1·kg-1). After a 48-hour standardization of nutrition and exercise the athletes were tested for 7 
plasma nitrate and nitrite concentrations, blood pressure, submaximal running economy at 10 8 
km·h-1 and 14 km·h-1 at 1% incline and 180 m as well as 5-km time-trial running 9 
performances. Plasma nitrite concentration following L-arginine+nitrate supplementation 10 
(319±54 nmol·L-1) did not differ from nitrate alone (328 ± 107 nmol∙L-1), and both were 11 
higher than placebo (149±64 nmol·L-1, p<0.01). There were no differences in physiological 12 
responses during submaximal running or in 5-km performance between treatments. The 13 
plasma nitrite concentrations indicate greater nitric oxide availability both following acute 14 
supplementation of L-arginine+nitrate and with nitrate alone compared to placebo, but no 15 
additional effect was revealed when L-arginine was added to nitrate. Still, there were no 16 
effects of supplementation on exercise economy or endurance running performance in 17 
endurance-trained cross-country skiers.  18 
 19 
 20 
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 3 
Introduction 1 
The signalling molecule nitric oxide (NO) has an important role in the regulation of many 2 
body functions including muscle contractility, metabolism, neuronal activity and host 3 
defence. NO is produced by NO synthases during the catalysis of L-arginine to L-citrulline 4 
(NO synthases dependent) and due to ingestion of nitrate-rich foods via the reduction of 5 
nitrate to nitrite (NO synthases independent). Increased NO availability may enhance oxygen 6 
and nutrient delivery to active muscles and thereby lower the ATP cost of muscle force 7 
production and improve the physiological responses related to endurance performance and 8 
recovery (1, 2). The mechanisms responsible for these effects have mainly been linked to 9 
improved muscle contractility, mitochondrial respiration and biogenesis, and the regulation of 10 
tissue blood flow (3-5).  11 
After ingestion of dietary nitrate, a reduction in the oxygen cost of submaximal exercise and 12 
improved tolerance of high-intensity exercise has been consistently reported in recreationally 13 
active adults with both acute and chronic supplementation (6-10). A decreased peak oxygen 14 
uptake without any changes in exercise performance (11, 12) indicates increased energy 15 
efficiency even at maximal aerobic workloads. Although studies in rodents have suggested 16 
that 5 to 7 days of nitrate supplementation might improve blood flow and contractile function 17 
predominantly in fast-twitch type II muscle fibers (13, 14), factors which might in turn 18 
increase performance in short-duration sprint exercise, the effect of nitrate supplementation 19 
on repeated sprint performance after nitrate supplementation in humans was not found in a 20 
recent study by Martin and colleagues (15).  21 
While most previous studies have examined moderately trained subjects, some recent studies 22 
have been carried out in highly trained athletes (16-20). Studies on elite cyclists did not find 23 
any changes in physiological responses or endurance performance using acute or chronic 24 
 4 
supplementations of nitrate compared to placebo (16-18). In endurance-trained cross-country 1 
skiers neither running economy nor endurance running performance were improved (19), 2 
whereas well-trained kayakers lowered the submaximal oxygen cost but did not improve 3 
performance with acute nitrate supplementation (20). Overall, the available evidence 4 
indicates that male athletes with a VO2max of ≥70 mL·kg-1·min–1 are unlikely to benefit from 5 
nitrate supplementation in their specialist discipline (2).  6 
Elite endurance athletes are well adapted to their specialist sport event and performance 7 
effects following dietary nitrate ingestion in most studies have not been found (2). One of the 8 
reasons for the lack of performance improvements following dietary nitrate ingestion in 9 
endurance-trained athletes may be due to higher baseline levels of NO (21, 22). Higher daily 10 
energy expenditure likely leads to higher intakes of nitrate and additionally training itself 11 
may elevate plasma nitrite and nitrate through enhanced production of NO via the NOS 12 
pathway (2). However, stronger stimulus of NO producing supplementation may be 13 
beneficial. Indeed, chronic supplementations of nitrate might be more effective than acute 14 
doses (23, 24), and higher acute doses of nitrate have been shown to be beneficial (25, 26). 15 
Targeting both pathways for increasing NO availability simultaneously by supplementing 16 
with L-arginine in addition to nitrate is a further option, but has not been examined to date.  17 
Although the physiological concentrations of L-arginine are generally sufficient to saturate 18 
endothelial nitric oxide synthase (27, 28), there is evidence that increased extracellular and 19 
plasma L-arginine levels still enhance endothelial NO production (28-30). This phenomenon 20 
is known as the L-arginine paradox. Therefore, many athletes use products with L-arginine to 21 
improve performance, but the effect of L-arginine supplementation on sport performance is 22 
controversial. While acute supplementation with 6 g of L-arginine (as part of a multi-nutrient 23 
supplement that included beetroot) increased plasma nitrite, reduced oxygen cost of 24 
 5 
submaximal work and enhanced high-intensity exercise tolerance (31), later work from the 1 
same laboratory (32) presented contrasting findings with acute administration of 6 g of pure 2 
L-arginine. In other studies L-arginine supplementation was shown to improve the respiratory 3 
response and cause faster O2 kinetics (33) and in combination with amino acids to improve 4 
repeated sprint performance (34) and muscle strength and power (35, 36) in moderately 5 
trained subjects. However, no study to date has shown ergogenic effects on L-arginine on 6 
elite athletes or examined performance effects of combined L-arginine and nitrate 7 
supplementation.  8 
Therefore, the purpose of the current study was to examine the effects of acute 9 
supplementation with L-arginine and nitrate on NO metabolites, running economy, endurance 10 
and sprint performance against in endurance-trained cross-country skiers. Experimentally, 11 
supplementation with L-arginine and nitrate was compared to supplementation with nitrate 12 
alone to reveal additional or interaction effects, and against placebo treatment. We 13 
hypothesized that combined L-arginine and nitrate supplementation would not alter the NO 14 
metabolites compared to supplementation of nitrate only and that exercise economy, 15 
endurance and sprint performance would remain unaltered between treatments in a group of 16 
elite endurance athletes.  17 
 18 
Methods 19 
Participants 20 
Nine eighteen year-old male junior-elite cross-country skiers from Norway (height 181.0 ± 21 
8.5 cm, body mass 74.2 ± 8.6 kg, maximal oxygen uptake (VO2max) 69.3 ± 5.8 mL∙kg-1∙min-1, 22 
heart rate maximum 199 ± 9 beats·min-1) provided written informed consent before 23 
volunteering to participate in this study. Ethical approval was provided by the Norwegian 24 
 6 
Regional Ethics Committee. Participants were a combination of national and international 1 
level junior skiers. All athletes were among the top 20 in the 2010 Norwegian Cup Series and 2 
had a training history of 505 ± 50 hours per year. 3 
Preliminary Measurements and Standardisations 4 
Preliminary tests were performed to determine each participant’s VO2max and maximal heart 5 
rate using an incremental running test to exhaustion on a motorised treadmill (Rodby RL 6 
2500 E. Rodby Innovation AB, Vänge, Sweden). An individualized treadmill protocol was 7 
applied (37). The incline was 10.5% and the speed was increased by 0.5 – 1.0 km∙h-1 every 8 
time the participant attained an oxygen uptake (VO2) that was stable during a 30-s period. 9 
VO2max was considered achieved if a plateau in VO2 was attained despite increased workload, 10 
and if the participant attained a respiratory-exchange ratio above 1.10. The VO2 plateau was 11 
defined as an increase in VO2 of less than 150 mL. Respiratory variables were measured 12 
continuously by a computerized metabolic system with mixing chamber (Oxycon Pro, Erich 13 
Jaeger GmbH, Hoechberg, Germany). The average of the three highest 10-s consecutive 14 
measurements determined VO2max. 20 μl blood samples were taken from the fingertips 1 and 15 
3 min after completion of the test to determine the blood lactate concentration (Biosen 5140, 16 
EKF Diagnostic GmbH, Magdeburg, Germany). Heart rate was recorded continuously using 17 
a Polar RS800 monitor (Polar Electro OY, Kempele, Finland). The highest consecutive 5-s 18 
heart rate measurement was recorded during the last minute of the test and defined the 19 
maximum heart rate. 20 
All preliminary testing and subsequent main trials were performed during the cross-country 21 
skiers’ off-season (in April and May) to ensure standardisation of training and remove the 22 
interference of competitions on the results of the study. At this time of year, all participants 23 
carried out approximately 50% of their endurance training as running (i.e. 5-8 hours per 24 
 7 
week), while the remainder of the endurance training was performed as roller skiing or 1 
cycling. Participants were experienced in performing maximal endurance running 2 
performances as part of their habitual training. To familiarise the participants with the 3 
specific experimental protocol and running time-trial distances, each participant performed 4 
two sprint and endurance running time-trial familiarisation sessions that were separated by 5-5 
10 days. Within-subject variation was minimised by testing at the same time of day and 6 
following a 2-hour fast. There was no significant difference in the time taken to complete the 7 
time-trials between preliminary tests 1 and 2, with a coefficient of variation of 0.8% and 8 
0.6% for the 180 m and the 5-km respectively. 9 
Experimental Tests 10 
Participants performed three main trials in a randomised, counterbalanced order, each 11 
separated by 1 week. Conditions were applied in a double-blind manner. Prior to the tests, 12 
participants ingested supplementation of either a) L-arginine (6 g) + nitrate (614 mg), b) 13 
nitrate (614 mg) + L-arginine-free placebo or c) L-arginine and nitrate-free placebo. Each 14 
trial consisted of two 5-min submaximal running tests on a treadmill, followed by 180 m and 15 
5-km running time-trials on an indoor track. Blood pressure and nitrate and nitrite content in 16 
the EDTA-plasma were tested before and between the various tests.  17 
Over the 48-h preceding the first experimental trial, each participant recorded their diet and 18 
replicated this diet before the second and third trial. Participants self-reported that they did 19 
not take any nutritional supplements in the 1-month prior to or during the study. Based on 20 
preliminary analyses of the participants’ nutrition, there was no requirement for participants 21 
to minimise the consumption of nitrate containing foods during the study period. Participants 22 
arrived for testing in a rested and hydrated state, at least 2 hours postprandial, and having 23 
avoided strenuous exercise, caffeine and alcohol in the 24 h preceding testing sessions. Each 24 
 8 
individual performed the same type of training in the week preceding all trials. The use of 1 
antibacterial mouthwash products was not permitted during the supplementation period as 2 
this has been shown to abolish the reduction of nitrate to nitrite in the oral cavity by 3 
commensal bacteria (38). 4 
Participants were seated in an upright position for 10 min before a venous blood sample was 5 
obtained. Samples were centrifuged at room temperature for 10 minutes and at 1000 G within 6 
2 min of collection. EDTA plasma was subsequently extracted and immediately frozen at -7 
80o C for later analysis of NO metabolites. Each participant was then supplemented with one 8 
opaque gelatine capsule containing either 1 g potassium nitrate (9.9 mmol giving 614 mg 9 
nitrate) or 1 g of maltodextrin as a placebo (MaxiNutrition, Hertfordshire, UK) 2.5 h prior to 10 
testing. Additionally each subject drank 500 mL of water. Capsules were consumed with a 11 
standardised breakfast and were well tolerated. Furthermore, participants were supplemented 12 
with additional six opaque gelatine capsules containing in total 6 g L-arginine or 6 g of 13 
maltodextrin as a placebo (MaxiNutrition, Hertfordshire, UK) 1 h prior to testing. The 14 
participants fasted and avoided strenuous physical activity or exercise in the period prior to 15 
testing. On returning to the laboratory, and after 10 min seated rest, additional blood samples 16 
were drawn. 2.5 h has been shown to coincide with peak plasma nitrite concentrations via 17 
dietary or pharmacological nitrate administration (39). Likewise maximal concentrations of 18 
nitrite are reached 60-90 min following ingestion of ~6 g of L-arginine (40).  19 
The blood pressure in the brachial artery was measured with subjects in a rested (10 minutes), 20 
seated position prior to each exercise bout via an automated sphygmomanometer (Microlife 21 
BP A100 plus, Microlife AG, Espenstrasse 139, 9443 Widnau, Switzerland). Three 22 
measurements were taken, and the mean of the two last was used in analysis.  23 
 9 
After a standardised low intensity (60-70% of maximal heart rate) 15-min warm-up, two 5-1 
min bouts of submaximal running were performed at 10 km∙h-1 and 14 km∙h-1 on a motorised 2 
treadmill at a 1% incline. The 1% incline was chosen to simulate flat terrain to compensate 3 
for the lack of air drag on the treadmill. The speeds employed here were based on pilot 4 
testing that established exercise intensities corresponding to approximately 55% and 75% of 5 
the participants’ maximal oxygen uptake. Pulmonary gas exchange data were measured 6 
during each 5-min stage and a further blood sample was drawn after the completion of 7 
submaximal exercise. Following a 15-min period of rest, participants completed a 180-m 8 
running time-trial on a 250-m indoor track, before a 5-km running time-trial was performed 9 
on the same track 15 min after execution of the 180 m. Performance times were recorded by 10 
using two synchronised stop-watches (Regnly RT3, Emit AS, Oslo, Norway). Further blood 11 
samples were drawn and blood pressure measured following the performance tests and 30 12 
min post-trial. 13 
Measurement of nitric oxide blood metabolites 14 
Ozone-based chemiluminescence set up 15 
Cleaving reagents were placed in a glass purge vessel with a rubber septum covered injection 16 
inlet. Oxygen free nitrogen gas was bubbled through the reagent mix, which was heated in a 17 
water bath on a thermostatically controlled hotplate. The reaction vessel, linked to a trap 18 
containing 25 mL sodium hydroxide (1N), was further connected to the NO analyser (Sievers 19 
NOA 280i, Analytix, UK) as described in detail previously (41-43). Ozone-based 20 
chemiluminescence signals obtained were transferred to Origin software (version 7) for 21 
smoothing using point-to-point averaging and peak area under the curve analysis. Test 22 
sample concentrations were calculated against the area under the curve obtained from a 23 
standard curve in each case. 24 
 10 
Plasma nitrate 1 
Vanadium chloride (0.05 mol∙L-1) in HCl (30 mL) heated to 80° C was used to reduce NO 2 
metabolites to NO. Standards (0.5-100 µmol∙L-1) of sodium nitrate (15 µL) were measured in 3 
each fresh cleavage reagent. Frozen plasma samples were thawed for 3 min at 37º C and 15 4 
µL of each plasma sample injected directly via the injection port. This assay is sensitive to <1 5 
µmol∙L-1 nitrate with accuracy better than ± 7 %. The total ozone-based chemiluminescence 6 
signal obtained was taken to reflect nitrate plus nitrite in the sample. In order to obtain a true 7 
nitrate value the corresponding level from tri-iodide measurement was then subtracted. 8 
Plasma nitrite and protein-bound nitric oxide 9 
A stock solution of acidic/tri-iodide cleavage reagent (70 mL) was prepared fresh each day. 10 
Frozen plasma samples were thawed for 3 min at 37º C and 200 µL plasma samples injected 11 
into 5 mL reagent at 50° C. This assay is sensitive to <10 nmol∙L-1 nitrite with accuracy better 12 
than ± 5 %. The ozone-based chemiluminescence signal obtained was taken to reflect nitrite 13 
in the sample. In order to account for protein-bound NO metabolites (RSNO, RNNO), in 14 
duplicate plasma samples to the above, we first removed nitrite (using addition acidified 15 
sulfanilamide) and recorded the residual ozone-based chemiluminescence signal, which was 16 
taken to reflect RSNO+RNNO in the sample. In all samples tested this was <5 % of the 17 
nitrite signal. 18 
Statistical Analysis 19 
All data were checked for normality using the Shapiro-Wilk test and are presented as mean ± 20 
standard deviation. Statistical significance was set at an alpha level of 0.05.  A linear mixed 21 
model was used to analyse effects of supplementation and to locate pairwise differences in 22 
physiological responses during submaximal exercise and in time-trial performances. A linear 23 
 11 
mixed model was also employed to identify effects of treatments and time and their 1 
interactions on nitrate and nitrite concentrations and for blood pressure. A random intercept 2 
was used to model within-subject correlations. To obtain a normal distribution, plasma nitrate 3 
concentrations were transformed into log-scale. Where significant overall effects were 4 
observed, post hoc tests determined the effects both between treatments at each time point 5 
and between time points within each treatment relative to baseline. Bonferroni correction was 6 
used to adjust for multiple comparisons. Sample size estimations were based on those 7 
reported by Lansley and colleagues (44) who calculated that a sample size of nine provided 8 
an 80% power to detect approximately 2% difference in sprint and endurance time-trial 9 
performances at an alpha level of 0.05. Statistical tests were conducted using SPSS version 10 
21.0 (Chicago, IL).  11 
 12 
Results 13 
At the two 5-min submaximal exercise bouts (10 and 14 km∙h-1), exercise intensity 14 
(expressed as percentage of VO2max), steady-state VO2, respiratory exchange ratio, 15 
ventilation, heart rate and blood lactate concentration did not differ between the three 16 
experimental conditions (Table 1). There were no significant differences in 5-km time-trial 17 
performances (L-arginine and nitrate =1011 ± 49 s, nitrate = 1016 ± 52 s, placebo = 1005 ± 18 
47 s) between supplementations. 180 m time-trial performance after L-arginine and nitrate 19 
supplementation (24.4 ± 0.8 s) did not significantly differ from placebo (24.3 ± 0.7 s), but 20 
differed from nitrate supplementation (24.1 ± 0.9, p = 0.04). For both time-trials, there were 21 
no consistent differences between participants’ trials such that no trial-order effects were 22 
apparent. The individual running performances achieved by the athletes were close to 23 
identical compared to those observed during preliminary repeatability testing. When analysed 24 
 12 
in 250 m running splits for the 5-km, there were no significant differences in performance 1 
times between treatments at any time-point, and overall pacing strategy was consistent 2 
between trials.  3 
--- Table 1 around here --- 4 
There were non-significant tendencies towards lower baseline plasma nitrate concentrations 5 
prior to the L-arginine and nitrate supplementation (23 ± 6 µmol∙L-1) compared with nitrate 6 
(32 ± 10 µmol∙L-1, p = 0.07) and placebo (35 ± 19 µmol∙L-1, p = 0.06). Nitrate concentrations 7 
were elevated after L-arginine and nitrate supplementation (296 ± 77 µmol∙L-1, p < 0.001), 8 
which did not differ from nitrate alone (335 ± 65 µmol∙L-1), but was significantly higher than 9 
with placebo (26 ± 16 µmol∙L-1, p < 0.001). Nitrate concentrations for L-arginine and nitrate 10 
supplementation remained significantly elevated above placebo concentrations throughout the 11 
study (all timepoints: p < 0.001), with no difference compared to nitrate alone (Figure 1A).  12 
Pre-supplementation baseline concentrations of plasma nitrite did not differ between trials (L-13 
arginine and nitrate = 158 ± 40 nmol∙L-1, nitrate = 124 ± 68 nmol∙L-1, placebo = 114 ± 35 14 
nmol∙L-1). Conversion of nitrate to nitrite was apparent from the marked increase in plasma 15 
nitrite concentrations after the L-arginine and nitrate supplementation (319 ± 54 nmol∙L-1, p < 16 
0.001), which did not differ from nitrate alone (328 ± 107 nmol∙L-1), but was significantly 17 
more elevated than with placebo (149 ± 64 nmol∙L-1, p < 0.01). Nitrite concentrations for L-18 
arginine and nitrate supplementation remained significantly elevated above its respective 19 
baseline level and placebo concentrations throughout the study (pre submax until post TT) (p 20 
< 0.05), but was normalised throughout recovery. Effects of supplementation with L-arginine 21 
and nitrate, and nitrate alone supplementation on nitrite levels were non-significant 22 
throughout the study (Figure 1B). 23 
--- Figure 1A-C around here --- 24 
 13 
Pre-supplementation baseline mean arterial blood pressure (MAP) did not differ between 1 
trials (L-arginine and nitrate = 96 ± 5 mmHg, nitrate = 98 ± 6 mmHg, placebo = 100 ± 7 2 
mmHg). There was a clear effect of time, but no effect of treatment on MAP, neither after 3 
supplementation (L-arginine and nitrate = 100 ± 10 mmHg, nitrate = 98 ± 6 mmHg, placebo 4 
100 ± 5 mmHg), nor throughout the study (time: p < 0.01, treatment: p = 0.80, Figure 1C). 5 
 6 
Discussion 7 
The current study investigated the effects of acute supplementation of L-arginine and nitrate 8 
on running economy, endurance and sprint performance in elite cross-country skiers. L-9 
arginine and nitrate supplementation was compared both against nitrate supplementation 10 
alone to reveal any additional effects of L-arginine and against placebo treatment. 11 
Supplementations with L-arginine and nitrate and with nitrate alone both demonstrated 12 
increased plasma nitrate and nitrite concentrations compared to placebo. However, no 13 
additional effect of L-arginine compared to nitrate alone was found. There were no 14 
differences in exercise economy or 5-km running time-trial performances between treatment 15 
conditions, whereas a slightly better sprint performance following nitrate supplementation 16 
compared to L-arginine and nitrate was revealed. 17 
There is no previous reported data concerning NO metabolites after acute supplementation of 18 
combined L-arginine and nitrate. Here, this supplementation significantly increased plasma 19 
nitrate and nitrite concentrations relative to placebo in a similar fashion as nitrate only. 20 
Nitrate and nitrite values for both treatment conditions were comparable to previous studies 21 
with acute nitrate supplementation (7, 8, 11, 19). Thus, the addition of L-arginine to nitrate 22 
supplementation did not have any additional effect on NO metabolites and should 23 
theoretically not give any additional ergogenic effect either. In contrast to what was found 24 
 14 
here, two previous studies reported higher baseline plasma nitrate and nitrite concentrations 1 
in trained populations compared to sedentary controls (21, 22). This indicated that well-2 
trained athletes may have increased baseline levels also without supplementation. However, 3 
the current and previous studies on endurance trained cross-country skiers (19) and cyclists 4 
(19, 45) contrast these arguments by showing normal baseline levels of plasma nitrate and 5 
nitrite in line with concentrations reported for untrained populations. Thus, the lack of 6 
ergogenic effects in the current study could not be explained by elevated baseline levels of 7 
NO metabolites. After supplementation the plasma nitrite concentration for the treatment 8 
conditions remained elevated until the finish of the 5 km time-trial. We therefore regard it 9 
unlikely that the lack of ergogenic effect found in the current study was caused by depletion 10 
of nitrite following the test battery executed before the time-trials.  11 
Neither steady-state oxygen cost, respiratory exchange ratio, ventilation, heart rate nor blood 12 
lactate concentration during low and moderate intensity treadmill running differed between 13 
supplementations and placebo. Thus, targeting both pathways for increasing the NO 14 
availability simultaneously with L-arginine and nitrate gave no improvements in exercise 15 
economy among these cross-country skiers compared to nitrate alone or placebo. Previous 16 
research done on endurance-trained cyclists (12) untrained or moderately trained subjects (6-17 
10) reports improved exercise economy following ingestions of nitrate. Although previous 18 
studies show positive effects also of L-arginine on exercise economy in untrained and 19 
moderately trained individuals, L-arginine was used in combination with other components 20 
such as beetroot and amino acids (31, 33-36), and it may be speculated that these other 21 
components than L-arginine induced the main effects as shown recently by Vanhatalo et al. 22 
(32). The lack of effect with L-arginine supplementation is supported by Abel and colleagues 23 
(46) and Colombani and colleagues (47) that reported no modification in endurance 24 
performance in a well-trained population with supplementation of combined L-arginine and 25 
 15 
L-aspartate. Although the combination L-arginine and nitrate had not been examined 1 
previously in elite athletes, no additional effect compared to nitrate could be expected due to 2 
the similar nitrate and nitrate responses. Consequently, the lack of supplementation effect on 3 
exercise economy found in this study is consistent with previous studies conducted with 4 
nitrate supplementation alone in a similar elite athlete population (16-20). Still, since Wylie 5 
et al. (26) showed that the effects of nitrate were dose dependent, future studies are needed to 6 
examine the effects of higher doses of nitrate on exercise economy. 7 
Also the 5-km endurance running performance was close to identical between treatment 8 
conditions. Although this study was the first to examine the performance effects of combined 9 
L-arginine and nitrate supplementation in elite athletes, the results correspond with previous 10 
studies assessing the effects of acute nitrate supplementation on well-trained populations.(16-11 
20). In an elite population the benefits in pulmonary, cardiovascular and neuromuscular 12 
systems induced by long-term training may overcome many of the potential effects from 13 
supplements targeting increased NO bioavailability. Repetitive exercise may result in an up-14 
regulation of endothelial NO activity (1), which may also be illustrated by the lack of effects 15 
on blood pressure in the current study. Whether exercise modes with more reliance of the 16 
upper body, hypoxic environments or chronic supplementation over a longer time periods 17 
would induce positive effects on exercise economy or endurance performance also in elite 18 
athletes require further examination. 19 
A novelty of the current study was that we examined the effects of acute L-arginine and 20 
nitrate supplementation on sprint running performance. Here, we found no differences 21 
between L-arginine and nitrate versus placebo, but reduced performance compared to nitrate 22 
supplementation alone. Since there was no change in NO metabolites when L-arginine was 23 
added to nitrate, explanation of this finding would be speculative, and further research is 24 
needed to exclude whether the addition of L-arginine may be harmful for sprint performance 25 
 16 
or if supplementation with nitrate alone induce positive effects. Previous studies indicate that 1 
up-regulated NO might improve sprint performance, possibly through enhanced blood flow 2 
and contractile function of type II muscle fibers (13, 14). However, these previous studies 3 
were done with 5 to 7 days of supplementation in rodents, and the effects of enhanced blood 4 
flow and muscle contractile function may only be realized following a longer 5 
supplementation period than used here. It could be that longer duration of exposure to nitrate 6 
supplementation might facilitate changes in mitochondrial and sarcoplasmic reticulum 7 
protein expression (4, 14). Still, improvements in repeated sprint performance (34) and 8 
muscle strength and power (35, 36) have been observed both for acute and chronic L-arginine 9 
supplementation in untrained or moderately trained subjects. Since we examined sprint 10 
performance effects in highly endurance-trained athletes in the current study, further 11 
elucidation of athletes with more Type II muscle fibers training for short-duration sprint 12 
events or more prolonged sprints (200-800 m) are required.  13 
 14 
Conclusions 15 
Compared to placebo, greater nitric oxide availability was induced both by acute 16 
supplementation of L-arginine and nitrate and with nitrate alone. However, no additional 17 
effects on NO biomarkers were revealed with the addition of L-arginine to nitrate 18 
supplementation which indicates that L-arginine induce no ergogenic effect in elite endurance 19 
athletes. Neither exercise economy nor endurance running performances were altered with 20 
supplementation in endurance-trained cross-country skiers.  This indicates that groups of elite 21 
athletes with a healthy daily nutrition combined with high dosages of endurance training do 22 
not alter physiological responses or endurance performance with acute supplementation of 23 
NO donors. The reasons for the slightly better sprint performance with nitrate 24 
 17 
supplementation compared to the combination with L-arginine and nitrate is unclear and 1 
needs further examination. Overall, training status of the subjects is an important factor 2 
linked to the ergogenic effect of NO and the absence of ergogenic effects of increased NO 3 
availability in endurance-trained athletes may be explained by the physiological and 4 
metabolic adaptations derived from chronic physical training. However, potential dietary 5 
effects on elite athletes are small and positive individual responses that this study could not 6 
detect may still occur. Furthermore, more studies are required to explore whether nutritional 7 
supplementations can increase NO availability and enhance performance in other elite athlete 8 
groups, exercise modes, hypoxic environments or with chronic supplementation.  9 
 10 
 11 
Acknowledgements 12 
This research was mainly funded by grants from The Norwegian University of Science and 13 
Technology. It was also partly supported by the UK Sport Council. MaxiNutrition provided 14 
supplements but no direct source of funding was received. The authors thank Ingerid Brænne 15 
Arbo, Ragnhild Røsbjørgen, Marte Kimo Rosenberg, Ida Larsen, Per-Øyvind Torvik and 16 
Simen Thorrud for their support in data collection and analysis during the study and Turid 17 
Follestad for support with the statistical analysis. The authors declare that they have no 18 
competing interests.  19 
 20 
 21 
 22 
 23 
 24 
 18 
References 1 
1. Bescos R, Sureda A, Tur JA, Pons A. The effect of nitric-oxide-related supplements 2 
on human performance. Sports Med. 2012;42(2):99-117. Epub 2012/01/21. 3 
2. Jones AM. Influence of dietary nitrate on the physiological determinants of exercise 4 
performance: a critical review. Applied physiology, nutrition, and metabolism = Physiologie 5 
appliquee, nutrition et metabolisme. 2014;39(9):1019-28. Epub 2014/07/30. 6 
3. Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH. Role of nitric oxide in the 7 
regulation of oxygen consumption in conscious dogs. Circulation research. 1994;75(6):1086-8 
95. Epub 1994/12/01. 9 
4. Larsen FJ, Schiffer TA, Borniquel S, Sahlin K, Ekblom B, Lundberg JO, et al. Dietary 10 
Inorganic Nitrate Improves Mitochondrial Efficiency in Humans. Cell Metab. 11 
2011;13(2):149-59. 12 
5. Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiological 13 
reviews. 2001;81(1):209-37. Epub 2001/01/12. 14 
6. Larsen FJ, Weitzberg E, Lundberg JO, Ekblom B. Effects of dietary nitrate on oxygen 15 
cost during exercise. Acta Physiol. 2007;191(1):59-66. 16 
7. Bailey SJ, Winyard P, Vanhatalo A, Blackwell JR, DiMenna FJ, Wilkerson DP, et al. 17 
Dietary nitrate supplementation reduces the O-2 cost of low-intensity exercise and enhances 18 
tolerance to high-intensity exercise in humans. J Appl Physiol. 2009;107(4):1144-55. 19 
8. Bailey SJ, Fulford J, Vanhatalo A, Winyard PG, Blackwell JR, DiMenna FJ, et al. 20 
Dietary nitrate supplementation enhances muscle contractile efficiency during knee-extensor 21 
exercise in humans. J Appl Physiol. 2010;109(3):943-. 22 
9. Lansley KE, Winyard PG, Fulford J, Vanhatalo A, Bailey SJ, Blackwell JR, et al. 23 
Dietary nitrate supplementation reduces the O-2 cost of walking and running: a placebo-24 
controlled study. J Appl Physiol. 2011;110(3):591-600. 25 
10. Vanhatalo A, Bailey SJ, Blackwell JR, DiMenna FJ, Pavey TG, Wilkerson DP, et al. 26 
Acute and chronic effects of dietary nitrate supplementation on blood pressure and the 27 
 19 
physiological responses to moderate-intensity and incremental exercise. Am J Physiol Regul 1 
Integr Comp Physiol. 2010;299(4):R1121-31. 2 
11. Larsen FJ, Weitzberg E, Lundberg JO, Ekblom B. Dietary nitrate reduces maximal 3 
oxygen consumption while maintaining work performance in maximal exercise. Free radical 4 
biology & medicine. 2010;48(2):342-7. Epub 2009/11/17. 5 
12. Bescos R, Rodriguez FA, Iglesias X, Ferrer MD, Iborra E, Pons A. Acute 6 
administration of inorganic nitrate reduces VO(2peak) in endurance athletes. Medicine and 7 
science in sports and exercise. 2011;43(10):1979-86. Epub 2011/03/17. 8 
13. Ferguson SK, Hirai DM, Copp SW, Holdsworth CT, Allen JD, Jones AM, et al. 9 
Impact of dietary nitrate supplementation via beetroot juice on exercising muscle vascular 10 
control in rats. The Journal of physiology. 2013;591(Pt 2):547-57. Epub 2012/10/17. 11 
14. Hernandez A, Schiffer TA, Ivarsson N, Cheng AJ, Bruton JD, Lundberg JO, et al. 12 
Dietary nitrate increases tetanic [Ca2+]i and contractile force in mouse fast-twitch muscle. 13 
The Journal of physiology. 2012;590(Pt 15):3575-83. Epub 2012/06/13. 14 
15. Martin K, Smee D, Thompson KG, Rattray B. No improvement of repeated-sprint 15 
performance with dietary nitrate. Int J Sports Physiol Perform. 2014;9(5):845-50. Epub 16 
2014/01/18. 17 
16. Bescos R, Ferrer-Roca V, Galilea PA, Roig A, Drobnic F, Sureda A, et al. Sodium 18 
nitrate supplementation does not enhance performance of endurance athletes. Medicine and 19 
science in sports and exercise. 2012;44(12):2400-9. Epub 2012/07/20. 20 
17. Christensen PM, Nyberg M, Bangsbo J. Influence of nitrate supplementation on 21 
VO(2) kinetics and endurance of elite cyclists. Scandinavian journal of medicine & science in 22 
sports. 2013;23(1):e21-31. Epub 2012/10/02. 23 
18. Lane SC, Hawley JA, Desbrow B, Jones AM, Blackwell JR, Ross ML, et al. Single 24 
and combined effects of beetroot juice and caffeine supplementation on cycling time trial 25 
performance. Applied physiology, nutrition, and metabolism = Physiologie appliquee, 26 
nutrition et metabolisme. 2014;39(9):1050-7. Epub 2014/08/27. 27 
 20 
19. Peacock O, Tjonna AE, James P, Wisloff U, Welde B, Bohlke N, et al. Dietary nitrate 1 
does not enhance running performance in elite cross-country skiers. Medicine and science in 2 
sports and exercise. 2012;44(11):2213-9. Epub 2012/08/10. 3 
20. Muggeridge DJ, Howe CC, Spendiff O, Pedlar C, James PE, Easton C. The effects of 4 
a single dose of concentrated beetroot juice on performance in trained flatwater kayakers. 5 
International journal of sport nutrition and exercise metabolism. 2013;23(5):498-506. Epub 6 
2013/04/13. 7 
21. Schena F, Cuzzolin L, Rossi L, Pasetto M, Benoni G. Plasma nitrite/nitrate and 8 
erythropoietin levels in cross-country skiers during altitude training. The Journal of sports 9 
medicine and physical fitness. 2002;42(2):129-34. Epub 2002/05/29. 10 
22. Jungersten L, Ambring A, Wall B, Wennmalm A. Both physical fitness and acute 11 
exercise regulate nitric oxide formation in healthy humans. J Appl Physiol. 1997;82(3):760-4. 12 
Epub 1997/03/01. 13 
23. Cermak NM, Res P, Stinkens R, Lundberg JO, Gibala MJ, van Loon LJ. No 14 
improvement in endurance performance after a single dose of beetroot juice. International 15 
journal of sport nutrition and exercise metabolism. 2012;22(6):470-8. Epub 2012/07/19. 16 
24. Cermak NM, Gibala MJ, van Loon LJ. Nitrate supplementation's improvement of 10-17 
km time-trial performance in trained cyclists. International journal of sport nutrition and 18 
exercise metabolism. 2012;22(1):64-71. Epub 2012/01/18. 19 
25. Hoon MW, Jones AM, Johnson NA, Blackwell JR, Broad EM, Lundy B, et al. The 20 
effect of variable doses of inorganic nitrate-rich beetroot juice on simulated 2,000-m rowing 21 
performance in trained athletes. Int J Sports Physiol Perform. 2014;9(4):615-20. Epub 22 
2013/10/03. 23 
26. Wylie LJ, Kelly J, Bailey SJ, Blackwell JR, Skiba PF, Winyard PG, et al. Beetroot 24 
juice and exercise: pharmacodynamic and dose-response relationships. J Appl Physiol (1985). 25 
2013;115(3):325-36. Epub 2013/05/04. 26 
27. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J 27 
Clin Invest. 1997;100(9):2153-7. 28 
 21 
28. Wu GY, Morris SM. Arginine metabolism: nitric oxide and beyond. Biochem J. 1 
1998;336:1-17. 2 
29. Xiao DS, Jiang L, Che LL, Lu LW. Nitric oxide and iron metabolism in exercised rat 3 
with L-arginine supplementation. Mol Cell Biochem. 2003;252(1-2):65-72. 4 
30. Maxwell AJ, Cooke JP. Cardiovascular effects of L-arginine. Curr Opin Nephrol 5 
Hypertens. 1998;7(1):63-70. 6 
31. Bailey SJ, Winyard PG, Vanhatalo A, Blackwell JR, DiMenna FJ, Wilkerson DP, et 7 
al. Acute L-arginine supplementation reduces the O2 cost of moderate-intensity exercise and 8 
enhances high-intensity exercise tolerance. J Appl Physiol. 2010;109(5):1394-403. Epub 9 
2010/08/21. 10 
32. Vanhatalo A, Bailey SJ, DiMenna FJ, Blackwell JR, Wallis GA, Jones AM. No effect 11 
of acute l-arginine supplementation on O-2 cost or exercise tolerance. Eur J Appl Physiol. 12 
2013;113(7):1805-19. 13 
33. Koppo K, Taes YE, Pottier A, Boone J, Bouckaert J, Derave W. Dietary arginine 14 
supplementation speeds pulmonary VO2 kinetics during cycle exercise. Medicine and science 15 
in sports and exercise. 2009;41(8):1626-32. Epub 2009/07/02. 16 
34. Buford BN, Koch AJ. Glycine-arginine-alpha-ketoisocaproic acid improves 17 
performance of repeated cycling sprints. Medicine and science in sports and exercise. 18 
2004;36(4):583-7. Epub 2004/04/06. 19 
35. Campbell B, Roberts M, Kerksick C, Wilborn C, Marcello B, Taylor L, et al. 20 
Pharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-21 
ketoglutarate in trained adult men. Nutrition. 2006;22(9):872-81. Epub 2006/08/25. 22 
36. Stevens BR, Godfrey MD, Kaminski TW, Braith RW. High-intensity dynamic human 23 
muscle performance enhanced by a metabolic intervention. Medicine and science in sports 24 
and exercise. 2000;32(12):2102-8. Epub 2000/12/29. 25 
37. Aspenes ST, Nauman J, Nilsen TIL, Vatten LJ, Wisloff U. Physical Activity as a 26 
Long-Term Predictor of Peak Oxygen Uptake: The HUNT Study. Medicine and science in 27 
sports and exercise. 2011;43(9):1675-9. 28 
 22 
38. Govoni M, Jansson EA, Weitzberg E, Lundberg JO. The increase in plasma nitrite 1 
after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. Nitric 2 
Oxide-Biol Chem. 2008;19(4):333-7. 3 
39. Kapil V, Milsom AB, Okorie M, Maleki-Toyserkani S, Akram F, Rehman F, et al. 4 
Inorganic Nitrate Supplementation Lowers Blood Pressure in Humans Role for Nitrite-5 
Derived NO. Hypertension. 2010;56(2):274-U174. 6 
40. Bode-Boger SM, Boger RH, Galland A, Tsikas D, Frolich JC. L-arginine-induced 7 
vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. British 8 
journal of clinical pharmacology. 1998;46(5):489-97. Epub 1998/12/02. 9 
41. Rogers SC, Khalatbari A, Gapper PW, Frenneaux MP, James PE. Detection of human 10 
red blood cell-bound nitric oxide. J Biol Chem. 2005;280(29):26720-8. 11 
42. Rogers SC, Khalatbari A, Datta BN, Ellery S, Paul V, Frenneaux MP, et al. NO 12 
metabolite flux across the human coronary circulation. Cardiovasc Res. 2007;75(2):434-41. 13 
43. Pinder AG, Rogers SC, Khalatbari A, Ingram TE, James PE. The measurement of 14 
nitric oxide and it's metabolites in biological samples by ozone-based chemiluminescence. In: 15 
Hancock EJT, editor. Redox-mediated signal transduction: Methods and protocols. NJ: 16 
Humana Press; 2008. p. 11-28. 17 
44. Lansley KE, Winyard PG, Bailey SJ, Vanhatalo A, Wilkerson DP, Blackwell JR, et 18 
al. Acute Dietary Nitrate Supplementation Improves Cycling Time Trial Performance. 19 
Medicine and science in sports and exercise. 2011;43(6):1125-31. 20 
45. Wilkerson DP, Hayward GM, Bailey SJ, Vanhatalo A, Blackwell JR, Jones AM. 21 
Influence of acute dietary nitrate supplementation on 50 mile time trial performance in well-22 
trained cyclists. European journal of applied physiology. 2012;112(12):4127-34. Epub 23 
2012/04/25. 24 
46. Abel T, Knechtle B, Perret C, Eser P, von Arx P, Knecht H. Influence of chronic 25 
supplementation of arginine aspartate in endurance athletes on performance and substrate 26 
metabolism - a randomized, double-blind, placebo-controlled study. Int J Sports Med. 27 
2005;26(5):344-9. Epub 2005/05/17. 28 
 23 
47. Colombani PC, Bitzi R, Frey-Rindova P, Frey W, Arnold M, Langhans W, et al. 1 
Chronic arginine aspartate supplementation in runners reduces total plasma amino acid level 2 
at rest and during a marathon run. European journal of nutrition. 1999;38(6):263-70. Epub 3 
2000/04/28. 4 
 5 
 6 
 7 
Figure captions 8 
Figure 1. Plasma nitrate (A) and nitrite (B) concentrations and mean arterial pressure (MAP) 9 
(C) before (Baseline) and 2.5 h after supplementation with combined L-arginine and nitrate, 10 
nitrate alone or placebo (Pre Submax), after submaximal treadmill running at 10 and 14 km h-11 
1 and before the 180 m and 5-km running time-trial performances (Pre TT), after the time-12 
trials (Post TT), and 30 min into recovery (Post Rec). Values are means and SD. 13 
* Time points significantly different between L-arginine + nitrate treatment and the placebo condition 14 
(p < 0.05).  15 
# Time points significantly different from baseline in the L-arginine + nitrate treatment (p < 0.05). 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 24 
TABLE 1. Oxygen uptake (VO2), respiratory exchange ratio (RER), ventilation, heart rate 1 
(HR), and blood lactate concentration measured during submaximal treadmill running at 10 2 
and 14 km·h-1 in nine male endurance-trained athletes after ingestion of L-arginine and 3 
nitrate, nitrate and placebo. 4 
 5 
 Nitrate + L-arginine Nitrate Placebo 
10 km·h-1 
VO2 (L·min
-1) 
 
2.84 ± 0.34 
 
2.82 ± 0.37 
 
2.83 ± 0.39 
VO2 (% of VO2max) 
RER 
Ventilation (L·min-1) 
55.6 ± 4.5 
0.88 ± 0.04 
66 ± 7 
55.2 ± 5.3 
0.88 ± 0.03 
66 ± 6 
 55.3 ± 4.9 
0.86 ± 0.03 
65 ± 5 
HR (% of HRmax) 
Lactate (mmol·L-1) 
 
14 km·h-1 
VO2 (L·min
-1) 
VO2 (% of VO2max) 
RER 
Ventilation (L·min-1) 
HR (% of HRmax) 
Lactate (mmol·L-1) 
74.1 ± 4.3  
1.1 ± 0.4 
 
 
3.90 ± 0.44 
76. 4 ± 5.6 
0.96 ± 0.05 
103 ± 11 
89.1 ± 0.9 
3.1 ± 1.2 
73.6 ± 5.7  
1.1 ± 0.5 
 
 
3.75 ± 0.66 
73.2 ± 9.8 
0.97 ± 0.04 
104 ± 9 
90.2 ± 3.7 
3.1 ± 1.4 
72.6 ± 4.3 
1.2 ± 0.5 
 
 
3.87 ± 0.46 
75.6 ± 5.14 
0.96 ± 0.37 
103 ± 9 
88.7 ± 2.7 
3.1 ± 1.4 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 25 
 1 
 2 
